Clinical Trials Logo

Hemostasis clinical trials

View clinical trials related to Hemostasis.

Filter by:

NCT ID: NCT04366752 Completed - COVID-19 Clinical Trials

Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy

THROMBOCOVID
Start date: April 22, 2020
Phase:
Study type: Observational

The understanding of haemostasis and inflammation cross-talk has gained considerable knowledge during the past decade in the field of arterial and venous thrombosis. Complex and delicately balanced interaction between coagulation and inflammation involve all cellular and humoral components. Elements of the coagulation system such as activated thrombin, fibrinogen or factor Xa may increase inflammation by promoting the production of pro-inflammatory cytokines, chemokines, growth factors and adhesion molecules that lead to a procoagulant state amplifying the pathological process. Recent evidence supports inflammation as a common pathogenic contributor to both arterial and venous thrombosis, giving rise to the concept of inflammation-induced thrombosis. Patients with infection of COVID-19 and severe pneumoniae seem to have higher risk of thromboembolism. Very few data are available regarding the biological disorders of coagulation in these patients. Th purpose of this project is to analyze hemostasis and coagulation of patients with infection of COVID-19 and severe pneumonia.

NCT ID: NCT04268992 Completed - Clinical trials for Coronary Artery Disease

Effect of Long-term Exercise on Haemostasis and Inflammation in Patients With Coronary Artery Disease

Start date: July 3, 2020
Phase: N/A
Study type: Interventional

Introduction: Regular exercise training improves prognosis in patients with coronary artery disease (CAD). This study investigates whether the beneficial effects of exercise can be partly explained by favourable changes in haemostasis and inflammation. Methods: 150 CAD patients are randomised to a supervised long-term exercise program (3 months) or usual care. Blood samples are obtained at baseline, 1.5 months, and 3 months after randomisation. Results: The investigators will evaluate platelet turnover and aggregation, coagulation, fibrinolysis, and inflammatory markers before and after short- and long-term exercise, and the two randomised groups will be compared. Perspectives: The present study will increase our knowledge of the beneficial mechanisms underlying the effect of exercise in CAD patients, potentially paving the way for improved exercise recommendations.

NCT ID: NCT03932240 Completed - Hemostasis Clinical Trials

In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)

Start date: August 13, 2019
Phase: Phase 3
Study type: Interventional

This primary aim of this study is to compare the in vivo effects of fibrinogen concentrate and cryoprecipitate on the neonatal fibrin network after surgery with cardiopulmonary bypass to develop effective and safe strategies for managing coagulopathies in neonates.

NCT ID: NCT03907111 Completed - Hemostasis Clinical Trials

Compare the Hemostatic Effectiveness of Chitosan Gauze With Traditional Gauze on Open Wound on 10 Participants.

Start date: October 2, 2015
Phase: N/A
Study type: Interventional

This study recruited 10 subject participants to compare the hemostasis gauze made by chitosan with traditional cotton gauze to see which one is better in bleeding time, bleeding volume, wound infection and wound healing speed when it is used in open wound treatment.

NCT ID: NCT03896061 Completed - Hemostasis Clinical Trials

A Videographic Study to Evaluate the Impact of a Pulsed Firing Technique on Staple Line Interventions in Laparoscopic Sleeve Gastrectomy

Start date: April 15, 2019
Phase:
Study type: Observational

Prospective, multi-center study will evaluate a pulsing technique with the ECHELON FLEX GST system for hemostasis at the staple line in laparoscopic sleeve gastrectomy procedures.

NCT ID: NCT03873181 Completed - Hemostasis Clinical Trials

Post-Market Evaluation of HEMOBLASTâ„¢ Bellows in Laparoscopic Abdominal, Gynecological, and Urological Surgery

NOBLE-Laparo
Start date: May 16, 2019
Phase:
Study type: Observational

A prospective, multi-center, multi-national single arm study to evaluate the performance and safety of HEMOBLASTâ„¢ Bellows in laparoscopic abdominal, gynecological, and urological surgery.

NCT ID: NCT03873168 Terminated - Hemostasis Clinical Trials

Post-Market Evaluation of HEMOBLASTâ„¢ Bellows in Open Gynecological, Urological, ENT, Head, Neck, and Vascular Surgeries

NOBLE-Open
Start date: May 9, 2019
Phase:
Study type: Observational

A prospective, multi-center, multi-national single arm study to evaluate the performance and safety of HEMOBLASTâ„¢ Bellows in open gynecological, urological, ENT and head and neck, and vascular surgery.

NCT ID: NCT03711916 Completed - Breast Cancer Clinical Trials

Post-Operative Outcomes of Low Thermal Dissection vs. Traditional Electrosurgery

Start date: March 17, 2017
Phase: N/A
Study type: Interventional

Low thermal dissection devices have been introduced as a tool to improve surgical outcomes. PlasmaBlade, a low thermal dissection device, has shown to be associated with effective cutting, and significantly lower temperature than traditional electrosurgical dissection device. Thus, low thermal devices would improve flap perfusion by decreasing the thermal injury resulted by the dissection. Looking into the use of low thermal devices in cases of mastectomy and immediate breast reconstruction has not been documented. The aim of this study is to determine if there are clinical flap perfusion, surgical site drainage, and pain scores differences between mastectomy flaps created using low thermal dissection device and those done with the standard care of Bovie cautery in order to warrant a formal study.

NCT ID: NCT03654560 Completed - Bleeding Clinical Trials

Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting

Start date: December 28, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to assess efficacy and safety of HemoStyp as an adjunct for management of secondary hemostasis in the operative setting.

NCT ID: NCT03430609 Active, not recruiting - Laparoscopy Clinical Trials

Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma

Endometrioma
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

Background: Endometriosis is defined by the presence of endometrial tissue outside the uterine cavity due to causes not yet fully elucidated. The disease affects approximately 2% of women of reproductive age and is associated with infertility. Approximately 17% to 44% of women with endometriosis exhibit endometrioma, or ovarian endometriosis. Laparoscopic cystectomy is currently considered the gold standard treatment for this problem, resulting in improvement of symptoms, a lower recurrence rate and a higher pregnancy rate among infertile patients. However, several studies have shown that this treatment is not free from risks because it is associated with reduction of the ovarian reserve due to accidental removal of ovarian cortex during stripping of the capsule or damage caused by the coagulation energy during hemostasis, even when performed by experienced surgeons. There is still controversy in the literature as to the cause of the reduction of the ovarian reserve, as the mere presence of endometrioma reduces ovarian function by itself. The aim of this study is to compare the effects of different hemostatic methods on the ovarian function of women subjected to laparoscopic surgery for ovarian endometrioma. Methods: Open-label randomized clinical trial to be conducted at Lauro Wanderley University Hospital from September 2017 to August 2020. Eighty-four patients will be randomly allocated to three groups according to the hemostatic technique used during laparoscopic surgery for ovarian endometrioma: bipolar coagulation, laparoscopic suture and hemostatic matrix. Ovarian function will be assessed by measuring serum anti-Mullerian hormone and follicle-stimulating hormone levels and by ultrasound antral follicle counts before surgery and 1, 3 and 6 months after surgery. The study was approved by the research ethics committee at the Medical Sciences Center, Federal University of Paraíba CAAE no. 71621717.9.0000.8069. Discussion: The present study intends to assess the ovarian function of patients with endometrioma subjected to laparoscopic surgical treatment, comparing different hemostatic techniques like bipolar coagulation versus suture versus hemostatic matrix with objective assessments of bipolar coagulation to avoid bias. Thus, the investigators expect to contribute data likely to dispel doubts on the subject.